Navigation Links
Results From Phase 3 EQUATE Trial of VIVUS' Qnexa Highlighted at European Congress on Obesity
Date:5/7/2009

centage of subjects achieving a weight loss of five percent or more. In total, the phase 3 program has enrolled approximately 4,500 patients.

Results from these studies are expected in the third quarter of 2009.

About EQUATE

The EQUATE study included 756 obese patients (599 females and 157 males) across 32 centers in the United States. The average baseline BMI of the study population was 36.3 kg/m2 and baseline weight was 101.3 kg. The study was a randomized, double-blind, placebo-controlled, prospective trial with subjects randomized to receive once-a-day treatment with mid-dose Qnexa (7.5 mg phentermine/46 mg topiramate CR), full-dose Qnexa (15 mg phentermine/92 mg topiramate CR), the respective phentermine and controlled-release topiramate constituents, or placebo. Patients had a four-week dose titration period followed by 24 weeks of treatment. Subjects were asked to follow a hypocaloric diet representing a 500-calorie/day deficit and advised to implement a simple lifestyle modification program.

About Obesity

More than 300 million people worldwide and approximately 30 percent of American adults (more than 60 million people) are obese, a chronic condition defined by having excess body fat. As the second leading cause of preventable death, obesity directly contributes to numerous life-threatening conditions including diabetes, cardiovascular disease, hypertension and stroke. Experts agree that even a modest weight loss of five percent of weight, maintained over time, can bring significant health benefits by lowering blood pressure and reducing the risk of diabetes and heart disease.

About Qnexa(TM)

Qnexa (Q-NEX-uh) is a proprietary, low dose, controlled release formulation of phentermine and topiramate that simultaneously addresses both appetite and satiety - the two main mechanisms that impact eatin
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
2. Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
3. Transcept Pharmaceuticals to Report First Quarter 2009 Results
4. Perceptive Informatics Survey Results Reveal Top Barriers to Implementing Adaptive Trial Designs
5. Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial
6. Fovea Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis
7. Study Results Present Paradigm Shift; REDUCE Trial Shows New Hope for the Risk Reduction of Prostate Cancer
8. Stallergenes S.A.: Positive Results From a Phase IIb/III Clinical Trial on the House Dust Mite Desensitization Tablet
9. Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients
10. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
11. Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... -- UBM Medica US announces that  OncoTherapy ... oncologists and other clinicians gain a better understanding of ... therapies and immunotherapies, discusses some of the latest news ... Every September, Blood Cancer Awareness Month is ... cancers—helping to increase survival rates and improve the quality ...
(Date:9/19/2014)... , Sept. 19, 2014 Larry J. Merlo ... CVS ), will speak before the National Press Club in ... the company,s recent move to stop selling tobacco products and ... future of health. "Dramatic changes in our health ... providers and government," Merlo has said. "CVS Health has a ...
(Date:9/19/2014)...  Alere Inc. (NYSE: ALR ), a ... today in support of President Barack Obama,s ... global leader in rapid diagnostics for infectious disease, we ... address the serious threat of antibiotic resistance. We look ... initiatives to promote the development of rapid point-of-care tests ...
Breaking Medicine Technology:OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2
... Inc. and Norgenix Pharmaceuticals, LLC today announced an agreement ... well as US territories and military bases for Femasys, ... to evaluate a woman,s fallopian tubes with standard ultrasound, ... medical device developer of women,s healthcare solutions. Norgenix Pharmaceuticals, ...
... /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical" or ... the largest network of radiotherapy and diagnostic imaging centers in ... ADS for its unaudited consolidated financial results for the second ... ended June 30, 2010. Second ...
Cached Medicine Technology:Femasys and Norgenix Announce Distribution Agreement for Groundbreaking New Device for Infertility Diagnosis 2Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 2Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 3Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 4Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 5Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 6Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 7Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 8Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 9Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 10Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 11Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011 12
(Date:9/21/2014)... Santa Clara, CA (PRWEB) September 22, 2014 ... 2.0 conference it has entered into a joint services ... in South Dakota, to deploy the CareSpan Virtual Clinic ... CareSpan and Avera eCARE plan to deploy their joint ... South Dakota and Wyoming where Avera eCARE is licensed. ...
(Date:9/21/2014)... one of the leading online stores of real and synthetic ... of human hair lace wigs inspired by 6 famous celebrities. ... the latest celebrity hairstyles are. , For people ... hairstyles to choose from: a style of yaki straight lace ... hot ombre red lace wig. People can go to the ...
(Date:9/21/2014)... 21, 2014 More than a quarter of ... fires start in one of two ways. The first type ... properly. The second type of dryer fire occurs when lint ... can also catch fire due to malfunctioning electrical systems so if ... take a look!) Here are some ways that you can ...
(Date:9/21/2014)... Expert witness work is in! That was ... 2014 Expert Witness Fees & Practices Survey. With litigation ... compensation for qualified and credentialed expert witnesses has now ... , The nearly 600 experts surveyed reported earnings ... an increase of 3.2% from ExpertPages’ 2012 survey. They ...
(Date:9/21/2014)... "I wanted to be able to ... sugary, foul-tasting energy drinks," said an inventor from Fresh ... to drink plain, old coffee. That is why I ... developed ENERG CHEWING GUM to provide a healthy energy ... formula contains nutritious vitamins, minerals and antioxidants. It also ...
Breaking Medicine News(10 mins):Health News:Avera eCARE and CareSpan form Collaboration to Deliver “Virtualized” Primary Care in the Dakotas and Wyoming 2Health News:Avera eCARE and CareSpan form Collaboration to Deliver “Virtualized” Primary Care in the Dakotas and Wyoming 3Health News:UniWigs New Arrivals Just In- Human Hair Lace Wigs Inspired By Famous Celebrities 2Health News:Restoration Local Offers Tips to Avoid Dryer Fires 2Health News:Restoration Local Offers Tips to Avoid Dryer Fires 3Health News:ExpertPages 2014 Survey Reports Expert Witness Hourly Fees Record All-Time Highs as Demand for Qualified Experts Continues to Grow 2
... Inc.,(NYSE: ZMH ; SWX: ZMH), a leader in the ... upcoming investor,conferences: -- November 27, 2007 -- 19th Annual ... York, New York, 9:00 a.m. Eastern Time -- December ... York, New York, 9:30 a.m. Eastern ...
... -- China Medical,Technologies Inc. (the "Company") (Nasdaq: ... company that develops, manufactures and markets advanced ... focused ultrasound tumor,therapy systems, today announces the ... and Dr. Yuedong Li as member for ...
... SALEM, Mass., Nov. 19 LaVoie Group, a ... today announced,that it has been selected as agency ... The GI Company, of Framingham, MA. Donna ... engaged in,providing strategic communications counsel and tactical execution ...
... Support for True Wealth Measures: Three-Quarters Say Governments, ... Environmental Progress, BRUSSELS, Belgium, Nov. 19 ... should look beyond,economics, and include health, social and ... believe that economic growth,alone is the most important ...
... November 19 ThalesNano Inc.,and the Christian ... Karl-Franzens-University in Graz today announced a scientific,collaboration ... focus,on the application of flow reactors for ... utilizing ThalesNano,s background in,continuous processing. ThalesNano and ...
... a dollar value has been attached to the high cost ... that reveals a massive annual cost of $34.3 billion -- ... grappling with pain. The price tag of pain includes ... MBF Foundation study The High Price of Pain: The Economic ...
Cached Medicine News:Health News:China Medical Technologies Announces Changes in Board of Directors and Appointment of Chief Technology Officer 2Health News:China Medical Technologies Announces Changes in Board of Directors and Appointment of Chief Technology Officer 3Health News:LaVoie Group Adds Two New Companies to Its Life Science Client Roster 2Health News:GLOBESCAN Survey for the BEYOND GDP Conference, European Parliament, Nov. 19th and 20th 2Health News:GLOBESCAN Survey for the BEYOND GDP Conference, European Parliament, Nov. 19th and 20th 3Health News:ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies 2Health News:ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies 3Health News:First study of Australia's high cost of pain reveals $34 billion price tag 2
... & Transfer System is a patent-pending disposable, ... procedures simpler for the physician and their ... an office-based technique. LipiVage™ improves upon traditional ... a need to centrifuge, decant or expose ...
... Type B) Injectable Solution, the only Botulinum ... demonstrated in numerous published studies to be ... Delivered as a purified, ready-to-use solution, ... a simpler way to significantly reduce abnormal ...
... is a simple, nonsurgical, physician-administered treatment that ... lines between the brows in people from ... is the only treatment of its type ... (FDA). BOTOX® Cosmetic is a purified ...
Inquire...
Medicine Products: